Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Novartis ADR representing 1 Ord Shs NVS

Healthcare

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory... see more

Add To Watchlist

Recent & Breaking News (NYSE:NVS)

Pre-Market Pulse: Dendreon, Novartis AG, Stryker, and Repros Therapeutics

PR Newswire January 15, 2014

RDInvesting Provides Investors with Free In-Depth Equity Reports on AZN, DD, GSK and NVS

Accesswire January 10, 2014

Taiwan Liposome Company Signs EU and US Collaboration Agreement for Antifungal Liposomal Amphotericin B Drug

Globe Newswire December 18, 2013

RDInvesting Provides Investors with Free In-Depth Equity Reports on ADI, GPC, MEG and NVS

Accesswire December 3, 2013

Grifols to acquire a Novartis diagnostics business unit for US$1,675 million

Canada NewsWire November 11, 2013

RDInvesting Provides Investors with Free In-Depth Equity Reports on LM, NVS, QLIK and XONE

Accesswire October 16, 2013

New England Has $9 Billion Worth of Reasons to Embrace the Pharmaceutical-Biotech Industry, an Industrial Info News Alert

Marketwired July 24, 2013

Trial Data, Recommendation, Manufacturing & Distribution Approval, and Recruitment Support Breakthrough Treatments - Research Report on Novo Nordisk, Novartis, GSK, Sanofi, and Neurocrine Biosciences

PR Newswire July 4, 2013

The Zacks Analyst Blog Highlights: Novartis, Microsoft, Oracle, Amazon and Yahoo

PR Newswire June 26, 2013

Breakthrough Therapy Designation Status, Top-Line Results, and Business Proposals Boost Long-Term Growth in Pharmaceutical Companies - Research Report on Novartis, AstraZeneca, GSK, Sanofi, and Rigel

PR Newswire June 26, 2013

Wall Street Fundamentals Releases New In-Depth Stock Reports on BIIB, MDVN, NVS and REGN

Accesswire June 24, 2013

Research Study Results Bring Hope for Combating Debilitating Diseases - Research Report on Johnson & Johnson, AbbVie, Lilly, Novartis and GlaxoSmithKline

PR Newswire June 12, 2013

Zacks Bull and Bear of the Day Highlights: Mueller, Cirrus Logic, Nektar Therapeutics, Novartis and Cubist Pharmaceuticals

PR Newswire June 6, 2013

Agere Augments Leadership with Pharmaceutical Manufacturing and Supply Chain Expert

Business Wire May 29, 2013

Novartis highlights new findings in advancing care for patients with 170 abstracts in breast, lung and blood cancers at ASCO and EHA

PR Newswire May 29, 2013

EmergingGrowth.com looks at Merus Labs with Approval to Re-Launch Emselex®/Enablex®

Accesswire May 7, 2013

Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts

PR Newswire April 26, 2013

Free Research Reports on BA, BYD, NVS and SO Issued by the Paragon Report

Marketwired April 25, 2013

Malaria No More Announces Innovative Partners For Its 'Power Of One' Malaria Campaign

PR Newswire April 25, 2013

Free Research Reports on NAT, NVS, RBY and YGE Issued by the Paragon Report

Marketwired April 3, 2013